Salvage therapy with mitoxantrone, etoposide, bleomycin and dexamethasone for refractory or relapsed aggressive non-Hodgkin’s lymphoma patients with a poor performance status or comorbidity

The treatment of refractory or relapsed aggressive non-Hodgkin’s lymphoma (NHL) in patients in a state of poor health is difficult due to their ineligibility to receive intensive salvage chemotherapy. In the present study, 16 refractory or relapsed aggressive NHL patients with a poor performance sta...

Descripción completa

Detalles Bibliográficos
Autores principales: LIN, XUEDE, SHI, XI, ZENG, WUCHA, ZHENG, MIN, HUANG, LIMING
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186623/
https://www.ncbi.nlm.nih.gov/pubmed/25295084
http://dx.doi.org/10.3892/ol.2014.2517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186623/
https://www.ncbi.nlm.nih.gov/pubmed/25295084
http://dx.doi.org/10.3892/ol.2014.2517

Ejemplares similares